Researcher Next
Create account
← Back to directory

Gerasimos Filippatos

Researcher Next ID · RN-021819

Researcher · Medicine

Brigham and Women's Hospital

Boston, United States

Sign in to saveSign in to claim
Not currently recruitingFunding unknown
Works count
1,156
Citation count
184,079
H-index
163
i10-index
726

Research interests

Medicine
Heart Failure Treatment and Management
Cardiovascular Function and Risk Factors
Diabetes Treatment and Management
Cardiac pacing and defibrillation studies
Hormonal Regulation and Hypertension

Publications

  • Finerenone in Heart Failure with Mildly Reduced or Preserved Ejection Fraction

    New England Journal of Medicine · 2024 · https://doi.org/10.1056/nejmoa2407107

  • 2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes

    European Heart Journal · 2023 · https://doi.org/10.1093/eurheartj/ehad192

  • Safety, tolerability and efficacy of up-titration of guideline-directed medical therapies for acute heart failure (STRONG-HF): a multinational, open-label, randomised, trial

    The Lancet · 2022 · https://doi.org/10.1016/s0140-6736(22)02076-1

  • Acetazolamide in Acute Decompensated Heart Failure with Volume Overload

    New England Journal of Medicine · 2022 · 10.1056/nejmoa2203094

  • Empagliflozin in Heart Failure with a Preserved Ejection Fraction

    New England Journal of Medicine · 2021 · 10.1056/nejmoa2107038

  • Corrigendum to: 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC

    European Heart Journal · 2021 · https://doi.org/10.1093/eurheartj/ehab648

  • 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure

    European Heart Journal · 2021 · https://doi.org/10.1093/eurheartj/ehab368

  • Cardiovascular and kidney outcomes with finerenone in patients with type 2 diabetes and chronic kidney disease: the FIDELITY pooled analysis

    European Heart Journal · 2021 · 10.1093/eurheartj/ehab777

  • Universal definition and classification of heart failure: a report of the Heart Failure Society of America, Heart Failure Association of the European Society of Cardiology, Japanese Heart Failure Society and Writing Committee of the Universal Definition of Heart Failure

    European Journal of Heart Failure · 2021 · https://doi.org/10.1002/ejhf.2115

  • Epidemiology, Pathophysiology and Contemporary Management of Cardiogenic Shock – A Position Statement from the Heart Failure Association of the European Society of Cardiology

    European Journal of Heart Failure · 2020 · 10.1002/ejhf.1922

  • SGLT2 inhibitors in patients with heart failure with reduced ejection fraction: a meta-analysis of the EMPEROR-Reduced and DAPA-HF trials

    The Lancet · 2020 · 10.1016/s0140-6736(20)31824-9

  • Ferric carboxymaltose for iron deficiency at discharge after acute heart failure: a multicentre, double-blind, randomised, controlled trial

    The Lancet · 2020 · 10.1016/s0140-6736(20)32339-4

  • Cardiac Myosin Activation with Omecamtiv Mecarbil in Systolic Heart Failure

    New England Journal of Medicine · 2020 · 10.1056/nejmoa2025797

  • Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure

    New England Journal of Medicine · 2020 · https://doi.org/10.1056/nejmoa2022190

  • The Use of Diuretics in Heart Failure with Congestion — A Position Statement from the Heart Failure Association of the European Society of Cardiology

    European Journal of Heart Failure · 2019 · 10.1002/ejhf.1369

  • 2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD

    European Heart Journal · 2019 · https://doi.org/10.1093/eurheartj/ehz486

  • Clinical Practice Update on Heart Failure 2019: Pharmacotherapy, Procedures, Devices and Patient Management. An Expert Consensus Meeting Report of the Heart Failure Association of the European Society of Cardiology

    European Journal of Heart Failure · 2019 · 10.1002/ejhf.1531

  • Heart Failure Association of the European Society of Cardiology Practical Guidance on the Use of Natriuretic Peptide Concentrations

    European Journal of Heart Failure · 2019 · 10.1002/ejhf.1494

  • How to diagnose heart failure with preserved ejection fraction: the HFA–PEFF diagnostic algorithm: a consensus recommendation from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC)

    European Heart Journal · 2019 · 10.1093/eurheartj/ehz641

  • Advanced Heart Failure: A Position Statement of the Heart Failure Association of the European Society of Cardiology

    European Journal of Heart Failure · 2018 · 10.1002/ejhf.1236

  • Type 2 Diabetes Mellitus and Heart Failure: A Position Statement from the Heart Failure Association of the European Society of Cardiology

    European Journal of Heart Failure · 2018 · 10.1002/ejhf.1170

  • Clinical Phenotypes and Outcome of Patients Hospitalized for Acute Heart Failure: The ESC Heart Failure Long-Term Registry

    European Journal of Heart Failure · 2017 · 10.1002/ejhf.890

  • 2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure

    Journal of the American College of Cardiology · 2017 · 10.1016/j.jacc.2017.04.025

  • 2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America

    Circulation · 2017 · 10.1161/cir.0000000000000509

  • Epidemiology and One-Year Outcomes in Patients With Chronic Heart Failure and Preserved, Mid-Range and Reduced Ejection Fraction: An Analysis of The ESC Heart Failure Long-Term Registry

    European Journal of Heart Failure · 2017 · 10.1002/ejhf.813

  • European Society of Cardiology Heart Failure Long-Term Registry (ESC-HF-LT): 1-Year Follow-Up Outcomes and Differences Across Regions

    European Journal of Heart Failure · 2016 · 10.1002/ejhf.566

  • Mitochondrial function as a therapeutic target in heart failure

    Nature Reviews Cardiology · 2016 · 10.1038/nrcardio.2016.203

  • 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS

    EP Europace · 2016 · https://doi.org/10.1093/europace/euw295

  • Contemporary Management of Acute Right Ventricular Failure: A Statement from the Heart Failure Association and the Working Group on Pulmonary Circulation and Right Ventricular Function of the European Society of Cardiology

    European Journal of Heart Failure · 2016 · 10.1002/ejhf.478

  • Current State of knowledge on Takotsubo Syndrome: A Position Statement from the Taskforce on Takotsubo Syndrome of the Heart Failure Association of the European Society of Cardiology

    European Journal of Heart Failure · 2015 · 10.1002/ejhf.424

  • Heart Failure: Preventing Disease and Death Worldwide

    ESC Heart Failure · 2014 · 10.1002/ehf2.12005

  • 2014 ESC/EACTS Guidelines on myocardial revascularization

    European Journal of Cardio-Thoracic Surgery · 2014 · 10.1093/ejcts/ezu366

  • Beneficial effects of long-term intravenous iron therapy with ferric carboxymaltose in patients with symptomatic heart failure and iron deficiency

    European Heart Journal · 2014 · 10.1093/eurheartj/ehu385

  • Are Hospitalized or Ambulatory Patients with Heart Failure Treated in Accordance with European Society of Cardiology Guidelines? Evidence from 12 440 Patients of the ESC Heart Failure Long-Term Registry

    European Journal of Heart Failure · 2013 · 10.1093/eurjhf/hft134

  • EUR Observational Research Programme: regional differences and 1-year follow-up results of the Heart Failure Pilot Survey (ESC-HF Pilot)

    European Journal of Heart Failure · 2013 · 10.1093/eurjhf/hft050

  • Serelaxin, recombinant human relaxin-2, for treatment of acute heart failure (RELAX-AHF): a randomised, placebo-controlled trial

    The Lancet · 2012 · 10.1016/s0140-6736(12)61855-8

  • Guidelines on the management of valvular heart disease (version 2012)

    European Journal of Cardio-Thoracic Surgery · 2012 · 10.1093/ejcts/ezs455

  • Third Universal Definition of Myocardial Infarction

    Journal of the American College of Cardiology · 2012 · 10.1016/j.jacc.2012.08.001

  • Guidelines on the management of valvular heart disease (version 2012)

    European Heart Journal · 2012 · 10.1093/eurheartj/ehs109

  • Third universal definition of myocardial infarction

    European Heart Journal · 2012 · 10.1093/eurheartj/ehs184

  • ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012

    European Journal of Heart Failure · 2012 · 10.1093/eurjhf/hfs105

  • Exercise Training in Heart Failure: From Theory to Practice. A Consensus Document of the Heart Failure Association and the European Association for Cardiovascular Prevention and Rehabilitation

    European Journal of Heart Failure · 2011 · 10.1093/eurjhf/hfr017

  • ESC Guidelines for the management of grown-up congenital heart disease (new version 2010)

    European Heart Journal · 2010 · 10.1093/eurheartj/ehq249

  • Guidelines for the management of atrial fibrillation

    European Heart Journal · 2010 · https://doi.org/10.1093/eurheartj/ehq278

  • Assessing and Grading Congestion in Acute Heart Failure: A Scientific Statement from the Acute Heart Failure Committee of the Heart Failure Association of the European Society of Cardiology and endorsed by the European Society of Intensive Care Medicine

    European Journal of Heart Failure · 2010 · 10.1093/eurjhf/hfq045

  • Guidelines for the diagnosis and management of syncope (version 2009): The Task Force for the Diagnosis and Management of Syncope of the European Society of Cardiology (ESC)

    European Heart Journal · 2009 · 10.1093/eurheartj/ehp298

  • Ferric Carboxymaltose in Patients with Heart Failure and Iron Deficiency

    New England Journal of Medicine · 2009 · 10.1056/nejmoa0908355

  • Guidelines for pre-operative cardiac risk assessment and perioperative cardiac management in non-cardiac surgery

    European Heart Journal · 2009 · 10.1093/eurheartj/ehp337

  • Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation

    European Heart Journal · 2008 · 10.1093/eurheartj/ehn416

  • Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation

    European Heart Journal · 2008 · 10.1093/eurheartj/ehn416

  • ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008

    European Journal of Heart Failure · 2008 · 10.1016/j.ejheart.2008.08.005

  • State of the Art: Using Natriuretic Peptide Levels in Clinical Practice

    European Journal of Heart Failure · 2008 · 10.1016/j.ejheart.2008.07.014

  • ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008

    European Journal of Heart Failure · 2008 · 10.1016/j.ejheart.2008.08.005

  • Guidelines on the diagnosis and management of acute pulmonary embolism

    European Heart Journal · 2008 · 10.1093/eurheartj/ehn310

Current projects

    No projects listed.